OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Cardiovascular Pharmacology and Therapeutics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
A Comprehensive Review of PCSK9 Inhibitors	43
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Di	30
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart	27
Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?	22
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database	20
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men	20
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data	19
Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways	18
Fondaparinux Sodium: Recent Advances in the Management of Thrombosis	16
COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges	15
The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction	14
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial	13
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension	13
Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms	12
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study	12
Umbrella Review on Non-Statin Lipid-Lowering Therapy	12
Cardioprotection and its Translation: A Need for New Paradigms? Or for New Pragmatism? An Opinionated Retro- and Perspective	11
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review	10
COVID-19: The Heart of the Matter—Pathological Changes and a Proposed Mechanism	10
Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation	10
Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model	10
The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction	10
Nucleolin Improves Heart Function During Recovery From Myocardial Infarction by Modulating Macrophage Polarization	9
Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction	9
Testosterone Deficiency, Long-Term Testosterone Therapy, and Inflammation	8

GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease	8
Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury	8
Remote Ischemic Perconditioning Ameliorates Myocardial Ischemia and Reperfusion-Induced Coronary Endothelial Dysfunction and Aortic Stiffness in Rats	7
Bioassays of Humoral Cardioprotective Factors Released by Remote Ischemic Conditioning in Patients Undergoing Coronary Artery Bypass Surgery	7
Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction	7
Left Ventricular Thrombus Therapy With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review and Meta-Analysis	7
Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation	7
Therapeutic Implications of COVID-19 for the Interventional Cardiologist	6
Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis	6
Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failure	6
ClC-3: A Novel Promising Therapeutic Target for Atherosclerosis	6
Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation	6
A Review of Pulmonary Arterial Hypertension Treatment in Extracorporeal Membrane Oxygenation: A Case Series of Adult Patients	6
Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation of Atrial Fibrillation in the Presence of Direct Oral Anticoagulants and Wide Spectrum of Body Mass Index	6
Targeting the Cholesterol Paradigm in the Risk Reduction for Atherosclerotic Cardiovascular Disease: Does the Mechanism of Action of Pharmacotherapy Matter for Clinical Outcomes?	6
High-Fructose Diet Induces Cardiac Dysfunction via Macrophage Recruitment in Adult Mice	6
A Comparison of Rate Control Agents for the Treatment of Atrial Fibrillation: Follow-Up Investigation of the AFFIRM Study	6
Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons	5
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?	5
Evaluation of TReatment With Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer: ERACER—An Observational Cohort Study	5
The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular Morbidity	5
NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoin	5
Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure	4
Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease	4
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry	4
Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial	4
Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling	3
Impact of Reticulated Platelets on Platelet Reactivity in Neonates	3
IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency	3
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol	3
Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension	3
Epicardial Adipose Tissue and Diabetic Cardiomyopathy	3
Treating Acute Myocardial Infarctions With Anti-Inflammatory Agents	3
Early Detection of Atrial Fibrillation in Community Pharmacies—CRIFAFARMA Study	3
Omega-3 Fatty Acids and Cardiovascular Disease: A Narrative Review for Pharmacists	3
Effect of Pre-Meal Metformin With or Without an Acute Exercise Bout on Postprandial Lipemic and Glycemic Responses in Metabolic Syndrome Patients: A Randomized, Open Label, Crossover Study	3
A Sodium Glucose Cotransporter 2 Inhibitor Fails to Improve Perivascular Adipose Tissue-Mediated Modulation of Vasodilation and Cardiac Function in Rats With Metabolic Syndrome	3
Comparison of Outcomes of Enoxaparin Bridge Therapy in HeartMate II versus HeartWare HVAD Recipients	3
Up-Titration of Sacubitril/Valsartan Among Patients With Heart Failure and Preserved Ejection Fraction	2
QT Prolongation in Critically Ill Patients With SARS-CoV-2 Infection	2
Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y₁₂ Inhibitors	2
Time-Dependent Effects of Individual and Combined Treatments With Nebivolol, Lisinopril, and Valsartan on Blood Pressure and Vascular Reactivity to Angiotensin II and Norepinephrine	2
Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions	2
Current-Induced Vasodilation Specifically Detects, and Correlates With the Time Since, Last Aspirin Intake: An Interventional Study of 830 Patients	2
Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery	2
Development of a Nomogram That Predicts the Risk of Coronary Heart Disease in Patients With Hyperlipidemia	2
Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan	2
Direct Ischemic Postconditioning After Carotid Endarterectomy in the Prevention of Postoperative Cerebral Ischemic Complications—Observational Case–Control Study	2
Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case–Control Studies	2
Secondary Prevention Medications Post Coronary Artery Bypass Grafting Surgery—A Literature Review	2

Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type	2
Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan	2
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled b	2
Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction	2
Upregulation of ATP-Sensitive Potassium Channels as the Potential Mechanism of Cardioprotection and Vasorelaxation Under the Action of Pyridoxal-5-Phosphate in Old Rats	2